drug price
-
News
WHO will certify the quality of generic insulin for low-income countries
The World Health Organization (WHO) has announced the launch of a pilot program to certify the quality of the human insulin generic…
Leggi » -
News
Catania. Trial for slander of the former president of the Order of Doctors: hearing postponed. He had defended 937 doctors accused of overprescribing osteoporosis drugs
He had criticized the verification procedures carried out by the ASP against 937 doctors in the province for alleged over-prescription of drugs…
Leggi » -
First floor
Report on RAI3, the dirty drug supply chain from India to Italy
On Rai3 I travel to the low-cost medicine factories where the New Delhi bacterium comes from, which has already made dozens…
Leggi » -
News
Over-the-counter medicines cost us up to six times more than in other European countries. Why?
We denounce a disgrace that involves unjustified bloodletting for Italian families Uncompetitive generics, non-refundability, small packs. In…
Leggi » -
News
Doctors Without Borders: 6 things big pharma doesn't want you to know
For decades, the global pharmaceutical industry has been using a deceptive narrative that justifies exorbitant prices as necessary and inevitable, and always…
Leggi » -
News
WHO approves the Italian proposal on the transparency of drug prices
We report the declaration of the Minister of Health Today is a historic day: WHO has approved our resolution on transparency…
Leggi » -
News
Paolo Cornaglia Ferraris presents ≪Brains, money, medicines≫. The case of "hepatitis C". Ed
Thursday 16 May 2019, from 6 pm, at the Feltrinelli Bookshop in Genoa (via Ceccardi), Paolo Cornaglia Ferraris presents the book…
Leggi » -
First floor
USA. Teva and nineteen other generic pharmaceutical companies accused of rigging the price fixing system
WASHINGTON (Reuters) - The United States has filed a lawsuit accusing 20 drug companies of generics, including Teva…
Leggi » -
First floor
Pfizer, Roche and Johnson & Johnson are the leaders of the global pharmaceutical industry
Pfizer, Roche and Johnson & Johnson account for 12.6% of the total value of the pharmaceutical industry worldwide, driven by the increase…
Leggi » -
First floor
Price of medicines: a reply to the Director of AIFA. With the fetish of transparency, the hedging difficulties of a State with delusions of omnipotence are unloaded on the sector
The medicines market is heavily regulated. Even before some specific strategies to contain pharmaceutical expenditure, such as…
Leggi »